Valid Ghana · FDA Ghana

LOLO TAMSULOSIN USP 0.4mg CAPSULES(Each hard gelatin capsule contains Tamsulosin 0.4mg)

amsulosin 0.4mg

FDA/SD.265-030349 amsulosin 0.4mg 0.4mg

What it does

Amsulosin is a medication used to help improve urine flow in men with an enlarged prostate.

Commonly used for: enlarged prostate (benign prostatic hyperplasia)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.265-030349
Registration date
2026-03-25
Expiry date
2031-04-01
Status
Valid
Active ingredient
amsulosin 0.4mg
Dosage form
amsulosin 0.4mg
Strength
0.4mg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Tns Pharma
Country of origin
INDIA
Manufacturer location
Road No: 42, Plot No: 4232, GIDC, Sachin, Surat, Gujarat 394230, India

Source: Food and Drugs Authority · fetched 2026-05-22 02:34:24 · updated 2026-10-27 04:00:03

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Amsulosin is a medication used to help improve urine flow in men with an enlarged prostate.

What it treats

  • enlarged prostate (benign prostatic hyperplasia)

How it works

Amsulosin relaxes the muscles in the prostate and bladder neck, making it easier to urinate.

Who it's for

This medication is for adult men experiencing difficulties with urination due to an enlarged prostate.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: amsulosin

BNF-referenced

Amsulosin is an alpha-1 adrenergic antagonist primarily used for the treatment of benign prostatic hyperplasia (BPH). It works by selectively blocking alpha-1 receptors in the smooth muscle of the prostate and bladder neck, leading to relaxation of these muscles and improved urinary flow. Amsulosin is well-tolerated and has a favorable side effect profile, making it a common choice for managing symptoms of BPH in men.

Indications

  • Benign prostatic hyperplasia (BPH)

Dosage

Adults: The typical adult dose of amsulosin is 0.4 mg once daily, taken after the same meal each day. In some cases, the dose may be increased to 0.8 mg once daily based on clinical response and tolerability.

Mechanism of action

Amsulosin selectively inhibits alpha-1A adrenergic receptors, primarily found in the prostate and bladder neck. This leads to smooth muscle relaxation, resulting in decreased resistance to urinary flow and alleviation of symptoms associated with BPH, such as difficulty in urination and increased urinary frequency.

Pharmacodynamics

The pharmacodynamic effects of amsulosin are characterized by its ability to reduce the tone of the prostate and bladder neck smooth muscles, resulting in an improved urinary stream. The specific targeting of the alpha-1A subtype reduces the incidence of systemic side effects commonly associated with non-selective alpha blockers.

Pharmacokinetics

Amsulosin is rapidly absorbed following oral administration, with peak plasma concentrations occurring approximately 4 to 6 hours after dosing. It has a high bioavailability due to a low first-pass effect. The drug is extensively metabolized in the liver, primarily via cytochrome P450 3A4. The elimination half-life is approximately 5 to 9 hours, with renal excretion of metabolites being the main route of elimination. Dose adjustments may be necessary in patients with significant renal or hepatic impairment.

Contra-indications

  • Severe hepatic impairment
  • Hypersensitivity to amsulosin or any of its components
  • Concurrent use with strong CYP3A4 inhibitors

Adverse effects

  • Dizziness
  • Headache
  • Hypotension
  • Nasal congestion
  • Retrograde ejaculation
  • Fatigue

Interactions

  • Increased risk of hypotension with other antihypertensive agents
  • Caution with PDE5 inhibitors due to potential additive effects on blood pressure
  • CYP3A4 inhibitors may increase amsulosin levels

Precautions

  • Caution in patients with a history of orthostatic hypotension
  • Monitor renal function in patients with moderate to severe renal impairment
  • Not recommended for use in women

Pregnancy

Amsulosin is not indicated in pregnancy; safety during pregnancy has not been established.

Breast-feeding

Amsulosin is not recommended during breastfeeding due to lack of data on excretion in human milk.

Storage

Store below 25°C. Protect from moisture.

Formulations

  • Amsulosin hydrochloride 0.4 mg capsules

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: amsulosin

PubChem CID 121829

Molecular formula: C20H28N2O5S

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.